M Schaafsma

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 826 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Cytarabine Dose for Acute Myeloid Leukemia

Bob Löwenberg, Thomas Pabst, Edo Vellenga et al. · New England Journal of Medicine · 2011 · 407 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

Jan J. Cornelissen, Bronno van der Holt, Gregor Verhoef et al. · Blood · 2008 · 179 citations · Full text

Medicine, Hematology, Oncology +17

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff et al. · Journal of Clinical Oncology · 2003 · 168 citations

Medicine, Geriatric Medicine, Oncology +13

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt et al. · Blood · 2003 · 163 citations · Full text

Medicine, Hematology, Oncology +14